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The innate immune system provides early host 
defense against viruses, bacteria, and tumor cells. 
Two of its cell lineages, NK and invariant NK T 
(iNKT) cells, do not require prior sensitization 
for effector function and play critical roles in 
both initially fighting infection and subsequently 
activating the adaptive immune response.
NK cells develop in the BM and share a 
common lymphoid progenitor with T and B 
cells (Kondo et al., 1997). The committed NK 
cell precursors (NKPs) express the shared IL-2 
and IL-15 receptor common  subunit (CD122; 
Rosmaraki et al., 2001). NK cell development 
is critically dependent on IL-15, as mice lack-
ing IL-15 or any component of its receptor or 
signaling have a block in NK cell differentia-
tion in the BM (DiSanto et al., 1995; Suzuki 
et al., 1997; Kennedy et al., 2000; Gilmour et al., 
2001; Vosshenrich et al., 2005). As NK cells 
mature, they sequentially acquire the cell surface 
receptors NK1.1 (in C57BL/6 mice), CD94- 
NKG2A, Ly49 receptors, and the 2-integrin 
CD49b (DX5; Hesslein and Lanier, 2011). 
Terminal maturation is accompanied by loss of 
CD27 expression and up-regulation of CD11b 
expression, together with optimal cytolytic 
function and IFN- production. NK cell spec-
ificity is fine-tuned by stochastic expression 
of activating and inhibitory receptors of the 
Ly49 family. Some activating Ly49 members 
can detect specific virus-encoded products 
(e.g., Ly49H recognizes the mouse cytomega-
lovirus m157 glycoprotein; Arase et al., 2002; 
Smith et al., 2002). Individual inhibitory Ly49 
members recognize distinct MHC class I allo-
types (e.g., Ly49C recognizes H2b in C57BL/6 
mice) and are important in self-recognition, 
whereas other inhibitory Ly49 genes produce 
receptors that do not recognize the autologous 
MHC class I (e.g., Ly49A in C57BL/6 mice; 
Orr and Lanier, 2011).
NKT cells share properties with both NK 
cells and T cells in that they express receptors 
of the NK cell lineage, including NK1.1 and 
members of the Ly49 family, along with a TCR. 
The majority of NKT cells express an invariant 
TCR (V14J18 in mice) that pairs with a 
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Natural killer (NK) and invariant NK T (iNKT) cells are critical in host defense against 
pathogens and for the initiation of adaptive immune responses. miRNAs play important 
roles in NK and iNKT cell development, maturation, and function, but the roles of specific 
miRNAs are unclear. We show that modulation of miR-150 expression levels has a differ-
ential effect on NK and iNKT cell development. Mice with a targeted deletion of miR-150 
have an impaired, cell lineage–intrinsic defect in their ability to generate mature NK cells. 
Conversely, a gain-of-function miR-150 transgene promotes the development of NK cells, 
which display a more mature phenotype and are more responsive to activation. In contrast, 
overexpression of miR-150 results in a substantial reduction of iNKT cells in the thymus 
and in the peripheral lymphoid organs. The transcription factor c-Myb has been shown to 
be a direct target of miR-150. Our finding of increased NK cell and decreased iNKT cell 
frequencies in Myb heterozygous bone marrow chimeras suggests that miR-150 differen-
tially controls the development of NK and iNKT cell lineages by targeting c-Myb.
© 2011 Bezman et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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RESULTS
Mice lacking miR-150 have cell-intrinsic defects  
in the development and maturation of NK cells
To define the role for miR-150 in NK cells, we generated 
mixed BM chimeras by reconstituting lethally irradiated mice 
with BM from WT (CD45.1+) and miR-150/ (CD45.2+) 
mice (Xiao et al., 2007). Analysis of the resulting chimeric 
animals (WT:miR-150/) allowed us to study the cell-
intrinsic effects of miR-150 deficiency on NK cells. We 
confirmed the absence of miR-150 in CD45.2+ NK1.1+ 
TCR NK cells (Fig. 1 A). Flow cytometric analyses of WT 
and miR-150/ compartments showed a significant reduction 
in the percentage of miR-150/ NK cells in the spleen 
(WT, 1.1 ± 0.1% vs. miR-150/, 0.8 ± 0.1%), liver (WT, 
3.6 ± 0.5% vs. miR-150/, 2.5 ± 0.4%), and blood (WT, 
1.1 ± 0.1% vs. miR-150/, 0.6 ± 0.1%; Fig. 1 B). Concur-
rently, the absolute numbers of miR-150/ NK cells were 
also reduced compared with that of WT NK cells in the 
spleen of WT:miR-150/ chimeras (WT, 0.30 × 106 ± 
0.05 × 106 vs. miR-150/, 0.10 × 106 ± 0.01 × 106; Fig. 1 C). 
The frequency of miR-150/ monocytes was similar to that 
of WT monocytes in peripheral blood (WT, 7.3 ± 0.2% vs. 
miR-150/, 7.4 ± 0.4%; P = 0.8; n = 10), and was even 
elevated in spleen of WT:miR-150/ chimeras (WT, 2.9 ± 
0.3% vs. miR-150/, 5.0 ± 0.6%; P = 0.008; n = 11). Fur-
thermore, we observed no significant differences between 
WT and miR-150/ donor cells in the monocyte compart-
ment, whereas miR-150/ NK cells were underrepresented 
(Fig. 1 D). Together, these results suggest that the reduced 
frequency of miR-150/ NK cells is not caused by a com-
petitive disadvantage of miR-150/ hematopoietic stem cells 
to reconstitute the host.
The maturation status of peripheral NK cells can be clas-
sified based on their expression of CD27 and CD11b, follow-
ing the pathway of CD27+ CD11b → CD27+ CD11b+ → 
CD27 CD11b+ (Chiossone et al., 2009). A significant accu-
mulation of more immature CD27+ CD11b and a corre-
sponding reduction of mature CD27 CD11b+ subsets was 
observed among miR-150/ NK cells in chimeric mice 
(Fig. 1 E). Similarly, miR-150/ NK cells showed increased 
expression of c-Kit, a receptor that is expressed on devel-
oping BM and immature splenic NK cells but is down-
regulated upon maturation (Fig. 1 F; Di Santo, 2006; Chiossone 
et al., 2009).
To determine whether the reduction of miR-150/ NK 
cells was the result of increased cell death, increased expan-
sion of immature NK cells, or both, we stained freshly isolated 
cells with Annexin V and a viability dye to assess apoptosis. 
There was no significant increase in apoptotic miR-150/ 
compared with WT NK cells (unpublished data). The rate of 
NK cell turnover at steady state (measured by BrdU incorpo-
ration during a 3-d labeling period) was also not different be-
tween WT and miR-150/ splenic NK cells (unpublished 
data). However, when WT and miR-150/ NK cells were 
co-transferred into a lymphopenic environment (Rag2/ x 
Il2rg/ mice) for 3 d, immature CD27+ miR-150/  
limited repertoire of TCR chains (V8, V7, or V2 in 
mice; Godfrey et al., 2010). These NKT cells, also referred to 
as iNKT cells, can be identified using CD1d tetramers loaded 
with the glycosphingolipid antigen -galactosylceramide 
(Matsuda et al., 2000). iNKT cells develop from CD4+CD8+ 
double-positive V14J18 TCR+ thymic precursors (Godfrey 
et al., 2010). After positive selection, iNKT-cell precursors 
down-regulate their expression of CD24 (HSA), and transition 
through several maturation stages accompanied by the ex-
pression of NK1.1, CD44, and CD122. After CD122 up-
regulation, iNKT cells proliferate in response to IL-15 and 
migrate from the thymus to the periphery, where they are 
most abundant in the spleen, liver, and BM.
Although much has been learned about the transcriptional 
regulation of NK and iNKT lineage development (Godfrey 
et al., 2010; Hesslein and Lanier, 2011), less is known about 
the posttranscriptional mechanisms that regulate NK and 
iNKT cells. microRNAs (miRNAs) are noncoding RNAs, 
expressed from endogenous genes, which act on protein-
encoding mRNAs, targeting them for translational repression 
or degradation (Bartel, 2004). Many miRNAs are expressed 
in a stage- and cell-specific fashion in the hematopoietic sys-
tem (Kuchen et al., 2010), and emerging evidence suggests 
that they regulate lymphocyte differentiation and function 
(Muljo et al., 2005; Cobb et al., 2006; Koralov et al., 2008; 
X. Zhou et al., 2008; Liston et al., 2008; Zhou et al., 2009; 
Fedeli et al., 2009). Deletion of the miRNA-processing en-
zymes Dicer or Dgcr8 leads to defects in NK cell activation, 
survival, and function during mouse cytomegalovirus infec-
tion (Bezman et al., 2010). In addition, loss of miRNAs in 
the BM or thymus leads to impaired iNKT cell development 
and function (Fedeli et al., 2009; Zhou et al., 2009; Seo et al., 
2010). These results, and the description of a subset of miRNAs 
differentially expressed in NK and iNKT versus other he-
matopoietic cells (Fedeli et al., 2009; Bezman et al., 2010; 
Kuchen et al., 2010), raise a question as to how individual 
miRNAs present in high amounts in these cell types contrib-
ute to specific aspects of their biology.
miR-150 is expressed in both mature NK and iNKT cells 
(Fedeli et al., 2009; Bezman et al., 2010; Fehniger et al., 2010) 
and, as in B and T lymphocytes, miR-150 is up-regulated 
during cellular maturation. Constitutive expression of miR-150 
blocks B cell development at the transition from the pro–B to 
pre–B cell developmental stage (Zhou et al., 2007). miR-150–
deficient mice have an accumulation of B-1 B cells in the 
spleen and peritoneal cavity (Xiao et al., 2007). In nonlymphoid 
lineages, where it drives megakaryocyte differentiation at the 
expense of erythropoiesis, miR-150 regulates the cell fate of 
megakaryocyte–erythroid progenitors (Lu et al., 2008). The 
transcription factor c-Myb has been shown to be a direct and 
functional target of miR-150 (Xiao et al., 2007; Lu et al., 2008). 
In this study, we show that miR-150 differentially affects the 
development of NK and iNKT cell lineages. These results show 
a critical developmental role for miR-150 in the innate immune 
system and suggest that there are distinct molecular pathways 
during the maturation stages of NK and iNKT cells.
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made IFN- (30% decrease in the frequency of miR-
150/ IFN-+ NK cells; Fig. 2 A). The amounts of IFN- 
produced by individual control and miR-150/ NK cells 
were similar (unpublished data). The reduction in IFN-–
producing cells might be caused by the reduction in the 
CD27 CD11b+ subset within the NK cell population, be-
cause this subset plays a dominant role in cytokine produc-
tion (Chiossone et al., 2009). We co-stained NK cells with 
anti-CD11b antibody and measured intracellular IFN- levels. 
Both CD11b+ and CD11b subsets of miR-150/ NK cells 
still produced less IFN- compared with that in WT NK 
cells (Fig. 2 B). Collectively, these experiments provide strong 
evidence for a cell-lineage intrinsic role for miR-150 in the 
generation and maturation of NK cells.
NK cells proliferated more than CD27+ WT NK cells, whereas 
mature CD27 miR-150/ NK cells proliferated less than 
their WT counterparts (Fig. 1 G). Thus, the immature phe-
notype of peripheral miR-150/ NK cells might be because 
miR-150/ NK cells spend more time at the immature 
stage, and CD27 miR-150/ NK cells have reduced pro-
liferative capacity compared with WT NK cells.
To determine whether the function of NK cells is af-
fected by miR-150 deficiency, freshly isolated splenic NK 
cells were stimulated either by cross-linking cell surface re-
ceptors, including NK1.1 and Ly49H, or by a combination 
of IL-12 and IL-18 cytokines. Whereas control NK cells pro-
duced high amounts of IFN- in response to stimulation, 
a significantly smaller proportion of miR-150/ NK cells 
Figure 1. Loss of miR-150 results in re-
duction and impaired maturation of NK 
cells. Mixed BM chimeras were generated by 
injecting WT and miR-150/ BM cells into 
irradiated hosts, which were analyzed 8–14 wk 
later. All stains contained CD45.1 and 
CD45.2 to distinguish between WT (CD45.1+) 
and miR-150/ (CD45.2+) populations. Three 
independent sets of WT:miR-150/chimeras 
were made. (A) RNA was isolated from CD45.1+ 
NK1.1+ TCR and CD45.2+ NK1.1+ TCR 
cells sorted from five chimeras. miR-150 level 
was quantified by qRT-PCR. Sno202 was used 
as normalization control. Data are presented as 
mean ± SEM (n = 3). (B and C) Cells were iso-
lated from the indicated tissues and stained for 
NK1.1 and TCR. (B) The frequencies of NK 
cells are shown as a percentage of WT and 
miR-150/ lymphocytes. Bar graphs represent 
mean percentages ± SEM of data (n = 11).  
(C) Absolute numbers of WT and miR-150/ 
NK cells ± SEM (n = 6). (D) Contribution of WT 
and miR-150/ cells to monocyte (CD11b+ 
NK1.1) and NK cell (NK1.1+ TCR) compart-
ments in peripheral blood of WT:miR-150/ 
chimeras. Data are from two independent chi-
meras experiments (BMQ [1] and BMQ [2]) with 
nine mice per experiment. (E and F) NK cell 
maturation was determined by staining sple-
nocytes with NK1.1, TCR, CD11b, CD27, and 
c-Kit antibodies. Gated NK1.1+ TCR cells  
are shown. Bar graph represents mean percent-
age ± SEM of data (n = 11 [E] and n = 8 [F]).  
(G) Equal numbers (106) of WT (CD45.1+) and 
miR-150/ (CD45.2+) NK cells were labeled 
with CFSE and adoptively transferred into 
Rag2/ x Il2rg/ mice. At 3 d after transfer, 
splenocytes were isolated and stained for 
NK1.1, TCR, CD45.2, CD45.1, and CD27. Histo-
grams show CFSE dilution by CD27+ (left)  
and CD27 (right) WT and miR-150/ NK 
cells. (B, C, E, and F) *, P < 0.05; **, P < 0.01.  
(D) ***, P < 0.001 (paired Student’s t test). Data 
shown are from two (A, D, and G) and at least 
five (B, C, E, and F) experiments.
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such as CD4, CD8, CD3, CD11c, Ter119, Gr-1, and CD19 
(Di Santo, 2006). A significant reduction of miR-150/  
NK cells was observed in the BM of WT:miR-150/ chi-
meras (WT, 1.1 ± 0.1% vs. miR-150/, 0.5 ± 0.1%; P = 
0.003; n = 9; Fig. 3 B). A scheme for the differentiation stages 
of developing BM NK cells has been 
refined based on cell surface markers 
(Di Santo, 2006). NKPs are defined 
as CD122+ NK1.1, as well as being 
lineage marker negative, and are lim-
ited to cells differentiating into NK 
cells (Rosmaraki et al., 2001). Acqui-
sition of NK1.1 marks the beginning 
of the immature NK cell (iNK) stage 
miR-150 promotes NK cell development in the BM
Because miR-150 is expressed early in NK cell develop-
ment, and is up-regulated during maturation (Fig. 3 A), we 
tested whether the absence of this miRNA influenced the 
development of NK cells in the BM. NK cells can be iden-
tified by the expression of CD122 and the absence of cell 
surface markers associated with mature hematopoietic lineages, 
Figure 2. Defective IFN- production in 
miR-150/ NK cells. NK cells from WT:miR-
150/ chimeras were stimulated by either  
immobilized mAbs (control IgG, NK1.1, and 
Ly49H), by incubation with IL-12 and IL-18, or 
left untreated. Cells were stained for NKp46, 
TCR, CD45.2, and CD45.1 (A) or NKp46, TCR, 
CD45.2, CD45.1, and CD11b (B), and intracellular 
IFN- was determined. (A) Bars represent mean 
percentages ± SEM of data (n = 6–9). Data shown 
are from five experiments. *, P < 0.05; **, P < 0.01. 
(B) Numbers indicate the percentage of CD11b+ 
or CD11b NK cells staining positive for IFN-. 
Data are representative of two experiments.
Figure 3. miR-150 promotes develop-
ment of NK cells in the BM. (A) NKP (lin-
eage [CD4, CD8, CD3, GR1, CD19, and 
Ter119]-negative, CD122+ NK1.1), iNK  
(lineage CD122+ NK1.1+ CD51+), and mature 
NK (mNK; lineage CD122+ NK1.1+ CD51 
CD49b+) cells were sorted from the BM of WT 
mice (n = 3). miR-150 expression was mea-
sured using qRT-PCR. Sno202 was used as a 
normalization control. Mean relative miR-150 
level ± SEM is shown. (B–D) BM developmen-
tal progression was determined by staining 
BM cells isolated from WT:miR-150/ chi-
meras with CD122, CD4, CD8, CD3, GR1, 
CD19, Ter119, CD51, CD49b, CD45.1, and 
CD45.2 antibodies. (B and C) The number of 
CD122+ (lineage CD122+; B) and NKP (lin-
eage CD122+ NK1.1; C) cells is shown as a 
percentage of either WT (CD45.1+) or miR-
150/ (CD45.2+) BM cells. Bar graphs repre-
sent mean percentages ± SEM of data. n = 9 
(B); n = 5 (C). (D) Analysis of CD51 and CD49b 
expression. Percentages of BM lineage 
CD122+ NK1.1+ cells positive for each marker 
among WT (CD45.1+) and miR-150/ 
(CD45.2+) cells are shown. Bar graph repre-
sents mean percentages ± SEM of data  
(n = 5). *, P < 0.05; **, P < 0.01. Data are  
from at least three experiments.
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context of Rosa26 locus (Xiao et al., 2007). Analogous to our 
studies with miR-150/ mice, we performed BM reconsti-
tution where lethally irradiated hosts were reconstituted with 
an equal mix of miR-150Tg and congenic WT BM cells. 
miR-150 expression level in sorted splenic miR-150Tg NK 
cells was 3.0 ± 0.7× higher than the endogenous level in 
splenic WT NK cells (Fig. 4 A).
We observed a significantly greater frequency of miR-
150Tg NK cells in the spleen (WT, 0.5 ± 0.1% vs. miR-
150Tg, 5.2 ± 1.1%), liver (WT, 2.6 ± 0.3% vs. miR-150Tg, 
21.3 ± 3.6%), and blood (WT, 0.7 ± 0.1% vs. miR-150Tg, 
2.7 ± 0.4%) of WT:miR-150Tg chimeric mice (Fig. 4 B). 
The absolute numbers of splenic miR-150Tg NK cells 
were also increased compared with that of WT NK cells 
(WT, 0.10× 106 ± 0.04 × 106 vs. miR-150Tg, 0.30 × 106 ± 
0.03 × 106; P = 0.003; n = 6; Fig. 4 C). Among miR-
150Tg NK cells, there was a significant reduction in the 
CD27+ CD11b subset in the spleen of WT:miR-150Tg 
chimeras (Fig. 4 C). This decrease in CD27+CD11b 
miR-150Tg NK cells was correlated with a concomitant 
mild increase in CD27+ CD11b+ and CD27 CD11b+ 
NK populations. Next, we tested the 
ability of miR-150Tg NK cells to pro-
duce IFN- upon activation with vari-
ous stimuli. NK cells isolated from WT:
miR-150Tg chimeras were stimulated by 
immobilized antibodies to several acti-
vating receptors or by a combination of 
(Rosmaraki et al., 2001; Kim et al., 2002). Expression of 
CD51 is up-regulated at this stage, and then down-regulated 
upon further maturation into mature NK cells when CD49b 
is expressed. Whereas the frequency of NKP cell subsets among 
CD122+ miR-150/ NK cells was not affected (Fig. 3 C), 
a significant accumulation of CD51+CD49b iNK cells was 
observed among CD122+ NK1.1+ miR-150/ NK cells 
(Fig. 3 D). Together with the corresponding increase in 
miR-150 expression at the iNK cell stage (Fig. 3 A), these 
results suggest that the reduction of miR-150/ NK cells 
occurs during the transition from immature to mature NK 
cells rather than earlier.
Mature hyperfunctional NK cells accumulate  
in miR-150Tg mice
Having shown that WT:miR-150/ chimeras display an 
impaired development of miR-150/ NK cells, we hypoth-
esized that increased miR-150 expression in BM could result 
in the accumulation of NK cells. To test this hypothesis, we 
used transgenic mice with moderate ectopic expression of 
miR-150 under the control of the CAG promoter in the 
Figure 4. Mature hyperfunctional NK cells 
accumulate in miR-150Tg mice. Mixed BM 
chimeras were generated by injecting WT and 
miR-150Tg BM cells into irradiated hosts, which 
were analyzed 8–14 wk later. All stains contained 
CD45.1 and CD45.2, as in Fig. 1. Two indepen-
dent sets of WT:miR-150Tg chimeras were made. 
(A) RNA was isolated from CD45.1+ NK1.1+ TCR 
and CD45.2+ NK1.1+ TCR cells sorted from five 
chimeras. miR-150 level was quantified by qRT-
PCR. Sno202 was used as normalization control. 
Data are presented as mean ± SEM (n = 5).  
(B) Cells from the indicated tissues were stained 
for NK1.1 and TCR. The numbers are shown as 
percentage of WT and miR-150Tg lymphocytes. 
Bar graph represent mean percentages ± SEM of 
data (n = 13). (C) NK cell maturation was deter-
mined by staining splenocytes with NK1.1, TCR, 
CD11b, and CD27 antibodies. Gated NK1.1+ 
TCR cells are shown. Bar graph represents 
mean percentage ± SEM of data (n = 11). (D) NK 
cells were stimulated as described in Fig. 2. Cells 
were stained for NKp46 and TCR, and intracel-
lular IFN- was determined. Bars represent mean 
percentages ± SEM of data (n = 6–9). *, P < 0.05;  
**, P < 0.01; ***, P < 0.001. (E) Numbers indicate 
the percentage of CD11b+ or CD11b NK cells 
staining positive for IFN-. Data are from two  
(A and E) and at least five (B–D) experiments.
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IL-12 and IL-18. After either type of stimulation, a larger 
fraction of miR-150Tg NK cells produced IFN- (40% 
increase in miR-150Tg as compared with WT NK cells; 
Fig. 4 D). Controlling for an increased number of NK cells 
expressing CD11b, a greater proportion of miR-150Tg 
NK cells generated IFN- compared with WT NK cells 
(Fig. 4 E). The amounts of IFN- produced by individual 
miR-150Tg NK cells, however, were similar to those made 
by control NK cells (unpublished data).
Because we observed the accumulation of mature miR-150Tg 
NK cells in WT:miR-150Tg chimeras, we tested whether this 
could be caused by faster expansion and/or lower susceptibil-
ity to apoptosis of peripheral miR-150Tg NK cells or altera-
tions in the development of BM miR-150Tg NK cells. We 
did not find a significant difference in either basal turnover 
rate or Annexin V staining of splenic miR-150Tg NK cells in 
comparison to WT NK cells (unpublished data). However, 
when adoptively transferred into Rag2/ x Il2rg/ mice, ma-
ture CD27 miR-150Tg NK cells underwent more rounds of 
proliferation compared with CD27 subset of WT NK cells 
(Fig. 5 A). Furthermore, there was a significant increase in 
the percentage of lineage CD122+ miR-150Tg NK cells in 
the BM (WT, 1.0 ± 0.2% vs. miR-150Tg, 7.8 ± 2.7%; P = 
0.04; n = 9) of WT:miR-150Tg chimeras (Fig. 5 B). Among 
miR-150Tg NK cells in the BM, there was also a significant 
reduction in iNK cell fraction (Fig. 5 C). Thus, a larger pro-
portion of mature miR-150Tg NK cells in the periphery of 
WT:miR-150Tg chimeras is likely caused by both increased 
maturation of miR-150Tg NK cells in the BM and expansion 
of mature miR-150Tg NK cells in the spleen.
In contrast to the NK cell compartment, the frequency 
of mature T cells was decreased in the peripheral lymphoid 
organs in WT:miR-150Tg chimeras (unpublished data). Analysis 
of thymocytes by flow cytometry revealed a partial block in 
T cell development, at the double negative-3 (DN3) to the 
double negative-4 (DN4) transition. These data are in agree-
ment with the phenotype observed in miR-150Tg mice 
(Xiao et al., 2007).
Partial loss of c-Myb recapitulates the phenotype of miR-
150Tg mice and leads to enhanced NK cell development
We explored the mechanism underlying miR-150–dependent 
NK cell development. Several studies in cell lines, as well as 
primary cells, have shown that a transcription factor c-Myb is 
a target of miR-150 (Xiao et al., 2007; Lin et al., 2008; Lu 
et al., 2008). We tested whether there is an inverse relation-
ship between miR-150 and c-Myb expression in NK cells. 
CD27+CD11b, CD27+CD11b+, and CD27CD11b+ sub-
sets of NK cells were purified from spleens of WT mice and 
analyzed for their expression of miR-150 and c-Myb mRNA. 
miR-150 expression level correlates with the progression of 
NK cell maturation, with the highest being in the most 
mature CD27 CD11b+ subset of NK cells (Fig. 6 A). The 
expression of c-Myb mRNA shows a reverse trend with the 
lowest being in CD27 CD11b+ subset of NK cells, consistent 
with a previous study showing c-Myb as a transcription factor 
Figure 5. Increased maturation and expansion of miR-150Tg cells 
in BM and spleen of WT:miR-150Tg chimeras. (A) 107 splenocytes 
from WT:miR-150Tg chimeras were labeled with CFSE and adoptively 
transferred into Rag2/ x Il2rg/ mice. At 5 d after transfer, spleno-
cytes were isolated and stained for NK1.1, TCR, CD45.2, CD45.1, and 
CD27. Histograms show CFSE dilution by CD27+ (left) and CD27 (right) 
subsets among WT (CD45.1+) and miR-150Tg (CD45.2+) NK cells.  
(B and C) The number of CD122+ (lineage CD122+; B) and iNK (lineage 
CD122+ NK1.1+ CD51+ CD49b; C) cells is shown as a percentage of either 
WT or miR-150Tg BM cells. Bar graphs represent mean percentages ±  
SEM of data. n = 9 (B); n = 5 (C). *, P < 0.05. Data are from two (A) and  
at least five (B and C) experiments.
differentially expressed by CD27+ CD11b and CD27 
CD11b+ subsets of NK cells (Chiossone et al., 2009).
Do changes in miR-150 expression inversely correlate 
with c-Myb expression? Because c-Myb mRNA levels 
were already low in freshly isolated splenic NK cells, we 
asked whether miR-150 deficiency leads to c-Myb up-
regulation. We found an increased level of c-Myb mRNA 
in miR-150/ NK cells compared with WT cells (Fig. 6 B). 
Transcription levels of the c-Myb targets c-kit and Bcl2 
(Greig et al., 2008) were also increased in sorted miR-150/ 
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significant increase in the percentage 
of lineage CD122+ Myb+/ NK cells 
compared with that of Myb+/+ cells 
(Myb+/+, 0.5 ± 0.1% vs. Myb+/, 1.3 ± 
0.2%; P = 0.005; n = 5; Fig. 6 E) in the 
BM of WT:Myb+/+ and WT:Myb+/ 
mice. Splenic Myb+/ NK cells expressed higher amounts of 
CD11b compared with their Myb+/+ counterparts (Fig. 6 F), 
suggesting that Myb+/ NK cells resembled more mature NK 
cells. Together, these results indicate the NK cell developmen-
tal phenotype observed in WT:Myb+/ chimeras resembles 
that in WT:miR-150Tg chimeras, suggesting that the latter 
could be explained, at least partially, by the control of c-Myb 
expression by miR-150. This is reminiscent of the observation 
that Myb+/ mice have fewer mature B-1 B cells and block at 
the transition from pro–B to pre–B cells, which is similar to 
the phenotype of miR-150Tg mice (Xiao et al., 2007).
Acquisition of the Ly49A NK cell receptor is dependent  
on the dosage of miR-150 and c-Myb
NK cells express a repertoire of activating and inhibitory 
receptors, including members of the Ly49 gene family and 
CD94 that complexes with NKG2A, NKG2C, or NKG2E. 
CD27+ CD11b and CD27 CD11b+ subsets of NK cells 
NK cells (Fig. 6 C), suggesting that the c-Myb protein level 
is likely to be altered in miR-150/ NK cells as well.
To ascertain whether the enhanced NK cell development 
induced by miR-150 overexpression might be the conse-
quence of c-Myb repression by miR-150, we studied mice 
with a partial loss of Myb. We generated two sets of chimeric 
mice by reconstituting irradiated hosts with an equal mix of 
BM from WT (CD45.1+) and experimental (Myb+/+ [2 doses 
of c-Myb gene] or Myb+/ [c-Myb heterozygous knockout]; 
CD45.2+) mice. The proportion of NK cells was significantly 
increased in the CD45.2+ compartment of WT:Myb+/ mice, 
compared with that in the WT:Myb+/+ chimeras (Fig. 6 D, 
III vs. IV in the flow cytometry plots). The frequency of NK 
cells among Myb+/ lymphocytes was also significantly higher 
than the frequency of NK cells among WT lymphocytes in 
WT:Myb+/ mice (Fig. 6 D, II vs. IV in the flow cytometry 
plots), thus suggesting a cell intrinsic mechanism for c-Myb 
regulation of NK cell generation. Furthermore, there was a 
Figure 6. Increased NK cell frequency in 
Myb+/ mice. (A) miR-150 and c-Myb expres-
sion in sorted NK cell subsets (n = 6 for each 
subset) defined by CD27/CD11b expression.  
(B and C) Levels of c-Myb, c-kit, and Bcl2 
mRNAs in miR-150/ NK cells. The amount 
of c-Myb, c-kit, and Bcl2 transcripts in sorted 
WT and miR-150/ NK cells were determined 
by qPCR with normalization to the amount of 
HPRT in each sample. Data are presented as 
mean ± SEM (n = 2–6). (D–F) Two sets of 
mixed BM chimeras were generated by inject-
ing either WT (CD45.1+) and Myb+/+ (CD45.2+) 
or WT (CD45.1+) and Myb+/ (CD45.2+) BM 
cells into irradiated hosts. All stains contained 
CD45.1 and CD45.2 to distinguish between 
WT (CD45.1+) and Myb (CD45.2+) populations.  
(D) Frequency of Myb+/ NK cells. Splenocytes 
from WT:Myb+/+ and WT:Myb+/ chimeras 
were stained for NK1.1 and TCR. Gated WT  
(I and II), Myb+/+ (III), and Myb+/ (IV) cells are 
shown. Bottom, bar graph represents mean 
percentage ± SEM of data from WT:Myb+/+  
(n = 6) and WT:Myb+/ (n = 7) mice. (E) The 
number of CD122+ (lineage CD122+) cells is 
shown as a percentage of either Myb+/+ or 
Myb+/ BM cells. Bar graphs represent mean 
percentages ± SEM of data (n = 5). (F) NK cell 
maturation was determined by staining sple-
nocytes with NK1.1, TCR, CD11b, CD27, 
CD45.2, and CD45.1 antibodies. Gated CD45.2+ 
NK1.1+ TCR cells are shown. *, P < 0.05;  
**, P < 0.01; ***, P < 0.001. Data are from two  
(A–C) and at least three (D–F) experiments.
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receptor acquisition is specific to Ly49A, as we observed sim-
ilar expression of Ly49G2 receptor in miR-150Tg and WT 
NK cells. These data suggest that the percentage of NK cells 
expressing the Klra1 gene in C57BL/6 mice encoding Ly49A 
is determined at an early point in NK cell development.
The presence of occasional Ly49A-bearing NK cells 
among miR-150Tg and Myb+/ NK cells suggests that normal 
Ly49A expression levels are not dependent on miR-150 or 
c-Myb dosage. This is evident from the mean fluorescence 
intensity (MFI) of Ly49A+ NK cells, which is identical among 
the different miR-150 mutant (Fig. 7 D), and between WT 
and Myb+/ (Fig. 7 E) NK cells. Therefore, miR-150 and 
c-Myb are necessary for the acquisition of Ly49A, but they 
are dispensable for Ly49A cell surface expression once its ex-
pression is initiated.
Ly49A is also expressed by a small fraction of memory 
CD8+ T cells (Coles et al., 2000). We found that Ly49A ex-
pression was present in higher fraction of miR-150/ T cells 
compared with WT T cells (WT, 0.40 ± 0.04% vs. miR-
150/, 0.80 ± 0.07%; P = 0.0001; n = 9); accordingly, 
Ly49A expression was displayed in lower proportion of miR-
150Tg T cells compared with control T cells (WT, 0.30 ± 
0.02% vs. miR-150Tg, 0.08 ± 0.02%; P < 0.0001 [n = 9]). 
Together, these data indicate that the dosage of miR-150 and 
c-Myb influences, in a cell-autonomous manner, the per-
centage of cells expressing Klra1. Because potential c-Myb 
binding sites exist in the upstream region of Klra1 (Tanamachi 
et al., 2004), c-Myb might represent the transcription factor 
that determines Klra1 gene variegation.
The development of iNKT cells is impaired  
in miR-150Tg and Myb+/ mice
Previous studies have shown that global miRNA loss as a 
result of Dicer deficiency results in severe defects in iNKT 
cell development (Fedeli et al., 2009; Zhou et al., 2009; Seo 
et al., 2010). iNKT cells developing in the thymus initially 
acquire V14-J18 TCR rearrangement, and then down-
regulate CD24, and finally up-regulate CD44 and NK1.1 as 
the last maturation step (Godfrey et al., 2010). Populations of 
thymic iNKT cells, identified using -galactosylceramide–
loaded CD1d tetramer (CD1d-tet; Matsuda et al., 2000), 
were purified and analyzed for their expression of miR-150 
(Fig. 8 A). Because miR-150 is up-regulated during iNKT 
cell maturation in the thymus, we hypothesized that miR-
150 could also play a role in the development of this lineage. 
We isolated thymocytes from WT:miR-150/ and WT:
miR-150Tg chimeras and stained for iNKT cells. Although 
the frequency of thymic miR-150/ iNKT cells was mildly 
decreased (1.5 ± 0.2-fold compared with that of WT cells), 
the proportion of thymic miR-150Tg iNKT cells was sig-
nificantly reduced (4.6 ± 0.8-fold compared with WT cells; 
Fig. 8 B). Analysis of CD1d-tet+ thymocytes showed 
that the majority of WT cells down-regulate CD24 and 
up-regulate NK1.1 (Fig. 8 C). In contrast, the proportion 
of CD24hi NK1.1 cells was significantly higher among 
miR-150Tg iNKT cells as compared with WT cells, whereas 
express a distinct NK cell repertoire (Hayakawa and Smyth, 
2006). In particular, CD27+ CD11b NK cells display higher 
expression of NKG2A, whereas CD27 CD11b+ NK cells 
contain a greater proportion of cells that express inhibitory 
Ly49 receptors (C and I isoforms), which recognize self-
MHC class I molecule, H-2b (C57BL/6 mice), and the acti-
vating Ly49 receptor Ly49D. Consistent with the higher 
frequency of immature CD27+ CD11b NK cell subset 
among miR-150/ NK cells, expression of NKG2A was 
higher and expression of Ly49C/I was lower in miR-150/ 
NK cells (Table I). Although we did not observe a corre-
sponding change in these receptor expressions in miR-150Tg 
NK cells, they did show an impaired expression of Ly49D. 
Expression of neither the activating Ly49D or Ly49H, nor 
the inhibitory NKG2A, Ly49C/I, and Ly49G2 receptors, 
was affected in Myb+/ NK cells.
The striking exception was Ly49A whose expression was 
exquisitely sensitive to the dosage of miR-150 and c-Myb. 
Ly49A is an inhibitory receptor that recognizes MHC class I 
molecules H2Dd and H2Dk (Orr and Lanier, 2011). The size 
of Ly49A subset was significantly higher in splenic miR-150/ 
NK cells (WT, 14.5 ± 0.8% vs. miR-150/, 17.5 ± 0.8%; 
P = 0.03; n = 14), and lower in splenic miR-150Tg NK cells 
(WT, 13.2 ± 0.8% vs. miR-150Tg, 4.0 ± 0.3%; P < 0.0001; 
n = 14; Fig. 7 A). Furthermore, Ly49A expression was lower in 
splenic Myb+/ NK cells compared with either internal WT 
control NK cells (WT, 17.1 ± 0.3% vs. Myb+/, 7.7 ± 0.3%; 
P < 0.0001; n = 3) or Myb+/+ NK cells (Myb+/+, 15.6 ± 1.2% 
vs. Myb+/, 7.7 ± 0.3%; P = 0.004; n = 3; Fig. 7 B). To de-
termine at what point in NK cell development miR-150 
mutant NK cells first show altered Ly49A expression, we 
measured Ly49A frequencies among NK cell populations in 
the BM of WT:miR-150Tg mice. NK1.1+ CD51+ iNK cells 
begin to acquire Ly49 receptors as they up-regulate CD49b 
(Fig. 7 C). miR-150Tg NK cells showed a marked reduction 
in Ly49A frequency at both intermediate (CD51+ CD49b+) 
and mature (CD51 CD49b+) stages. This deficit in Ly49A 
Table I. Receptor repertoire of NK cells from miR-150/, 
miR-150Tg, Myb+/+, and Myb+/ mixed BM chimeras
Receptor miR-150/ miR-150Tg Myb+/+ Myb+/
WT WT WT WT
Ly49H 48.5 ± 4.4 58.5 ± 1.5a 51.0 ± 2.7 54.6 ± 1.2
53.3 ± 3.9 47.3 ± 2.6 46.9 ± 0.6 51.7 ± 0.6
Ly49D 43.5 ± 1.8 36.3 ± 2.0a 41.9 ± 3.3 48.1 ± 2.7
47.6 ± 1.7 44.0 ± 1.6 46.6 ± 4.1 49.0 ± 0.8
NKG2A 55.3 ± 2.3b 55.3 ± 2.9 52.0 ± 1.9 47.6 ± 0.9
43.4 ± 1.3 50.7 ± 2.0 43.9 ± 1.5 44.1 ± 0.6
Ly49C/I 26.2 ± 1.2b 41.3 ± 2.1 33.6 43.3
38.9 ± 1.6 37.4 ± 2.6 33.7 40.9
Ly49G2 48.4 ± 1.6 38.4 ± 1.6 36.8 ± 10.1 37.3 ± 0.6
46.4 ± 0.9 40.8 ± 1.9 44.7 ± 1.4 43.7 ± 0.3
aSignificant P < 0.01 compared with WT.
bSignificant P < 0.001 compared with WT.
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in addition to NK1.1 (Benlagha et al., 2002). miR-150Tg 
iNKT cells had lower proportion of Ly49G2-expressing cells 
compared with that among WT iNKT cells (WT 49.2% ± 
2.5% vs. miR-150Tg 36.6% ± 3.7%; P = 0.05 [n = 3]), al-
though they had normal levels of CD122 (unpublished 
data). The observed decrease of miR-150Tg iNKT cells was 
also found in spleen (3.7 ± 0.6-fold compared with WT 
cells; Fig. 8 D). Together these data suggest that optimal dose 
of miR-150 is necessary for the development and matura-
tion of iNKT cells.
the proportion of mature stage CD24lo NK1.1+ miR-150Tg 
iNKT cells was reduced. Analysis of miR-150/ iNKT devel-
opmental intermediates revealed a mild reduction in the 
fully mature CD24lo NK1.1+ iNKT cells; however, the 
data were not statistically significant. As CD24 is normally 
down-regulated during positive selection, these results sug-
gest that miR-150 is important during the positive selec-
tion of iNKT cells. The terminal maturation stages during 
iNKT cell development involve up-regulation of Ly49 recep-
tors (Gapin et al., 2001) and CD122 (Matsuda et al., 2002) 
Figure 7. Acquisition of the Ly49A NK cell receptor is dependent on the dosage of miR-150 and c-Myb. (A) Splenocytes were isolated from 
the mixed WT:miR-150/ and WT:miR-150Tg chimeras described in Figs. 1 and 4, respectively, and stained with NK1.1, TCR, CD45.1, CD45.2, and 
Ly49A antibodies. Histograms show percentages of Ly49A+ cells in WT (CD45.1+) and miR-150 mutant (CD45.2+) NK cells. Cumulative data are shown in 
a scatter plot. Each symbol represents an individual mouse (n = 14). Horizontal lines represent mean values. (B) Splenocytes were isolated from the 
mixed WT:Myb+/+ and WT:Myb+/ chimeras described in Fig. 6, and stained as described in A. Histograms show percentage of Ly49A+ cells in WT 
(CD45.1+) and c-Myb mutant (CD45.2+) NK cells. Each symbol in the scatter plot represents an individual mouse (n = 3). Horizontal lines represent mean 
values. (C) Percentage of Ly49A+ (left) and Ly49G2+ (right) cells among WT and miR-150Tg NK cell subsets at various stages of maturation in the BM.  
(D and E) The mean fluorescence intensity (MFI) values of Ly49A staining in miR-150/, miR-150Tg and WT Ly49A+ NK cells (D) or between WT, Myb+/+, 
and Myb+/ Ly49A+ NK cells (E). Data are shown as mean MFI ± SEM. n = 11 (D); n = 3 (E). *, P < 0.05; ***, P < 0.001. Data are from nine (A and D), three 
(B and E) and two (C) experiments.
2726 Role of miR-150 in NK and iNKT cells | Bezman et al.
more immature (CD24hi NK1.1 and CD24hi NK1.1) pheno-
type (unpublished data). These data suggest that the iNKT cell 
developmental phenotype observed in miR-150Tg chimeras is 
at least partially caused by the alteration in c-Myb levels.
DISCUSSION
Although miR-150 was initially appreciated as a key miRNA 
in B cell development (Zhou et al., 2007), it is becoming 
increasingly apparent that it also functions in other cell types 
of the hematopoietic system. miR-150 modulates lineage 
fate in megakaryocyte progenitors, driving differentiation 
Myb deficiency in the thymus results in a complete absence 
of iNKT cells (Hu et al., 2010). If miR-150 regulates iNKT 
cell development by regulating c-Myb, partial loss of c-Myb 
would be predicted to have the same effect on the develop-
ment of this lineage as the overexpression of miR-150. To test 
this hypothesis, we stained for iNKT cells in the spleen of 
WT:Myb+/+ and WT:Myb+/ chimeras. The frequency of 
Myb+/ iNKT cells was significantly reduced (2.8 ± 1-fold 
compared with WT cells; Fig. 8 E). We also examined the iNKT 
cell population in the thymus of WT:Myb+/+ and WT:Myb+/ 
chimeras and found fewer Myb+/ iNKT cells that exhibited 
Figure 8. Partial ablation of c-Myb phenocopies impaired iNKT cell development in miR-150Tg mice. (A) Up-regulation of miR-150 during iNKT 
cell maturation in the thymus. Developmental intermediates (CD24hi NK1.1, CD24lo NK1.1, and CD24lo NK1.1+) of thymic PBS57-loaded CD1d tetramer 
(CD1d-tet)+ TCR+ iNKT cells were sorted from WT mice. miR-150 expression was measured using qRT-PCR. Sno202 was used as a normalization control. 
Mean relative miR-150 level ± SEM is shown (n = 3). (B) Percentage of miR-150Tg CD1d-tet+ TCR+ cells in thymus of WT:miR-150Tg chimeras. A repre-
sentative dot-plot analysis of CD1d tetramer and TCR staining is shown. Bottom, box plots represent mean percentages ± SEM of data from WT:miR-
150/ (n = 5) and WT:miR-150Tg (n = 7) chimeras. (C) Frequency of CD24hi NK1.1, CD24lo NK1.1, and mature CD24lo NK1.1+ iNKT cells among 
CD1d-tet+ NK1.1+ TCR+ cells from thymus of WT: miR-150/ and WT:miR-150Tg chimeric mice. Bar graphs depict the mean ± SEM for the proportion 
of developmental intermediates within miR-150/ (left) and miR-150Tg (right) CD1d-tet+ iNKT cells. n = 4 for each group. (D and E) Percentage of splenic 
miR-150Tg and Myb+/ CD1d-tet+ iNKT cells. Bar graphs depict mean ± SEM for the proportion of CD1d-tet+ TCR+ iNKT cells in the spleens of WT:miR-
150/ (n = 11), WT:miR-150Tg (n = 11), WT/Myb+/+ (n = 6), and WT/Myb+/ (n = 7) mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Data are from two  
(A and C) and at least three (B, D, and E) experiments.
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sites in the Myb 3UTR or a genetic rescue of miR-150/ 
phenotype by the partial loss of c-Myb will ultimately be re-
quired to determine to what extent contributions of target 
genes other than c-Myb might explain the phenotypes of NK 
and iNKT cell compartments.
Several transcription factors that regulate the develop-
ment of NK cells have been described (Hesslein and Lanier, 
2011). Members of the Ets family of transcription factors 
control several aspects of hematopoiesis in general, and NK 
cell development in particular. PU.1 deficiency results in the 
generation of reduced numbers of NKP and mature NK cells 
(Colucci et al., 2001), whereas deficiencies in Ets1 and MEF 
result in severe defects in the development of NK and iNKT 
cells (Barton et al., 1998; Walunas et al., 2000). T-bet, a 
member of the T-box family of transcription factors, controls 
various aspects of NK cells (Hesslein and Lanier, 2011). Mice 
lacking T-bet have a profound, cell-intrinsic defect in their 
ability to generate mature NK and iNKT cells (Townsend 
et al., 2004). Both cell lineages fail to complete maturation, 
leading to decreased numbers in the periphery. Bcl11b is a 
zinc finger protein that plays an essential role in specifying 
T cell fate by both up-regulating T cell–specific genes and 
suppressing NK cell genes (Li et al., 2010). When Bcl11b was 
deleted, T cells acquired expression of NK cell lineage mole-
cules including CD122, T-bet, NKp46, and NKG2A re-
ceptors, perforin, and IFN- after in vitro culture. Perhaps 
the accumulation of miR-150Tg NK cells is a result of repro-
grammed NK-like cells with altered Bcl11b expression? This 
scenario is unlikely as the mouse Bcl11b gene does not con-
tain the miR-150 seed sequence in its 3 or 5 UTR or its 
coding sequence (Dweep et al.. 2011), and there is no evi-
dence suggesting that Bcl11b mRNA levels are altered in 
miR-150 mutant NK cells (unpublished data). c-Myb has re-
cently been shown to be required for the development and 
function of iNKT cells (Hu et al., 2010). Further investiga-
tion of a role for c-Myb in NK cell development requires loss 
of c-Myb specifically in NK cell lineage. With the develop-
ment of a NK cell–specific Cre mice (Eckelhart et al., 2011), 
it will now be feasible to test the hypothesis that c-Myb is a 
negative regulator of NK cell development.
The factors that control Ly49 gene expression are begin-
ning to be defined. We show here that miR-150 and c-Myb 
are required for the acquisition of the Ly49A receptor. Several 
scenarios are possible to explain the reduced frequency of 
Ly49A+ NK cells in miR-150 transgenic and c-Myb hetero-
zygous mice. First, miR-150 and c-Myb may be involved in 
the formation of Ly49 receptor repertoire at the level of its 
adaptation to the MHC class I environment. This is unlikely for 
Ly49A because Ly49A is not known to recognize the MHC 
class I H2b allele in C57BL/6 mice (Orr and Lanier, 2011), and 
our studies were conducted in mixed BM chimeras where 
both WT and mutant cells develop in the same environment. 
Alternatively, the reduced frequency of Ly49A+ NK cells 
might result from differences within the CD27+ CD11b and 
CD27+ CD11b cell subsets between miR-150Tg and Myb+/ 
NK cells. To this end, we co-stained NK cells from different 
of megakaryocytes at the expense of erythroid cells (Lu et al., 
2008). Overexpression of miR-150 in hematopoietic stem 
cells leads to a mild increase in granulocytes (Zhou et al., 
2007). In this study, we have demonstrated an important role 
for miR-150 in directing that development and maturation 
of the NK and the CD1d-restricted NKT cell lineages as 
well. In the absence of miR-150, peripheral numbers of NK 
cells are decreased; the cells appear to be halted at a stage be-
fore final maturation, and their ability to produce IFN- after 
activation is diminished. That miR-150 promotes NK cell 
development and maturation was corroborated in experiments 
in which miR-150 was ectopically expressed in BM. This led 
to an accumulation of more mature hyperfunctional NK cells. 
Furthermore, proper dosage of miR-150 is also necessary for 
the development and maturation of iNKT cells. Importantly, 
we find that miR-150 acts in a cell-intrinsic manner in both 
lineages. Because NK cells and iNKT cells come from differ-
ent committed precursors and develop in different locations 
(Di Santo, 2006; Godfrey et al., 2010), miR-150 most likely 
acts independently in both cell types after lineage commit-
ment. Given that miR-150 expression is low in the progeni-
tor populations of each of these lineages compared with 
mature NK and iNKT cells, it is unlikely that it would regu-
late the formation of these committed precursors.
miR-150 effects in NK and iNKT cells are at least par-
tially mediated by its target gene Myb. Transcript levels of 
c-Myb and its target genes c-kit and Bcl2 are increased in 
miR-150/ NK cells. Partial ablation of c-Myb pheno-
copies increased NK cell frequency and impaired iNKT cell 
development observed in miR-150Tg chimeric mice. It is 
possible that other miR-150 target genes may also contribute 
to the NK and iNKT cell developmental phenotypes ob-
served in miR-150/ and miR-150Tg chimeric mice. Bio-
informatics analyses predict hundreds of target genes for each 
miRNA (Rajewsky, 2006). Only a few of these, however, 
may represent targets with a significant biological function or 
be relevant in a particular cellular context. Pim-1, a predicted 
target of miR-150 (Xiao et al., 2007), is known to stimulate 
c-Myb activity (Leverson et al., 1998), indicating that 
miR-150 may suppress multiple genes in the c-Myb path-
way. The expression pattern of Pim-1 mimics c-Myb, and is 
inversely correlated with that of miR-150 during NK cell 
activation (Heng and Painter, 2008), suggesting that it might 
be functionally relevant for the regulation of NK cells. Re-
cently, miR-150 was shown to target the transcription factor 
Egr2 (Wu et al., 2010). Egr2 is an essential regulator of iNKT 
cell development and is thought to control iNKT cell prolif-
eration and apoptosis (Lazarevic et al., 2009). Interestingly, 
although expressed in developing NK cells (unpublished 
data), Erg2 is not necessary for NK cell development (Lazarevic 
et al., 2009), suggesting that miR-150–mediated regulation 
of Eg2 levels might have functional consequences for iNKT 
but not NK cells. Furthermore, another miR-150 target, the 
purinergic P2X7 receptor (L. Zhou et al., 2008), has been 
implicated in regulating iNKT cell activation (Kawamura 
et al., 2006). Targeted mutagenesis of the miR-150–binding 
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development in the thymus (Xiao et al., 2007; Zhou et al., 
2007). Another unexpected finding was the relatively un-
changed number of miR-150/ iNKT cells. Perhaps devel-
oping iNKT cells are exquisitely sensitive to the dose of 
miR-150 and its regulated genes; too much miR-150 inhib-
its iNKT cell development, whereas lack of miR-150 also 
leads to a mild reduction. It is also possible that miR-150 
might have both a negative and a positive role at different 
stages of iNKT cell development, depending on the expres-
sion of the target genes it regulates. This context-specific 
property may perhaps explain why miR-150 expression var-
ies between different lineages and different developmental 
stages within the hematopoietic system (Kuchen et al., 2010). 
In conclusion, this is the first study showing the requirement 
of a specific miRNA for the development and maturation of 
NK and iNKT cells.
MATERIALS AND METHODS
Mice. M. Ansel (University of California, San Francisco, San Francisco, CA) 
provided miR-150/ mice. K. Rajewsky (Harvard Medical School, Bos-
ton, MA) provided miR-150Tg BM cells (Xiao et al., 2007). T.P. Bender 
(University of Virginia Health System, Charlottesville, VA) provided Myb+/+ 
and Myb+/ BM cells (Bender et al., 2004). To generate mixed BM chime-
ras, 6–8-wk-old CD45.1-congenic C57BL/6 mice (National Cancer Insti-
tute, Frederick, MD) were lethally irradiated with 1,000 rads, and then 
reconstituted with a 1:1 mix of CD45.1 and either miR-150/, miR-150Tg, 
Myb+/+, or Myb+/ BM cells. Mixed BM cells were then retroorbitally in-
jected into the host mice. Mice were analyzed 8–14 wk after reconstitution. 
CD45.1+ C57BL/6 mice were purchased from the National Cancer Insti-
tute. Rag2/ x Il2rg/ C57BL/6 mice were purchased from Taconic. Experi-
ments were done according to the University of California, San Francisco 
Institutional Animal Care and Use Committee guidelines.
Flow cytometry. Fc receptors on cells isolated from peripheral blood, 
spleen, liver, BM, and thymus were blocked with anti-CD16 + CD32 mAb 
(clone 2.4G2) at 10 µg/ml before surface staining. Cells were stained 
with antibodies against NK1.1, TCR, CD45.1, CD45.2, CD27, CD11b, 
NKp46, CD122, CD49b, CD51, CD4, CD8, CD11c, CD19, GR1, Ter119, 
Ly49H, Ly49D, CD94, NKG2A, Ly49C/I, Ly49G2, Ly49A, CD24, and 
CD117 (from BD, eBioscience, or BioLegend). Intracellular IFN- staining 
was performed according to the manufacturer’s instructions (BD). iNKT 
cells were identified with a Pacific blue–conjugated mouse CD1d tetramer 
either unloaded or loaded with PBS57. For apoptosis analysis, freshly isolated 
splenocytes were first stained with antibodies against NK1.1, TCR, 
CD45.1, CD45.2, and Live/Dead fixable near-IR stain (Invitrogen), washed, 
and then stained with PE-conjugated Annexin V (BD), according to the 
manufacturer’s protocol. For BrdU labeling, mice were injected i.p. with 
200 µg of BrdU (Sigma-Aldrich) in PBS every 24 h for 3 consecutive days, 
and then sacrificed. For the detection of incorporated BrdU, cells were first 
stained for surface antigens, and then fixed, permeabilized, treated with 
DNase I, and stained with APC-conjugated anti-BrdU mAb (BD). Flow 
cytometry was performed on an LSRII, and data were analyzed with FlowJo 
software (Tree Star).
CFSE labeling and adoptive transfer. Enriched (60–80% NK1.1+ 
TCR) cells from WT and miR-150/ mice (mixed at a 1:1 ratio) or 
splenocytes from WT:miR-150Tg chimeras were labeled for 8 min with 
10 µM CFSE in accordance with the manufacturer’s instructions (Invitro-
gen), and transferred into Rag2/ x Il2rg/ mice. 3 (Fig. 1) or 5 d (Fig. 5) 
later, NK cells were analyzed by flow cytometry for CFSE dilution and ex-
pression of CD27.
chimeric mice with anti-CD11b antibody and measured 
Ly49A expression. Both CD27+ CD11b and CD27 CD11b+ 
subsets among miR-150Tg NK cells showed a lower propor-
tion of Ly49A+ NK cells compared with WT cells; similar 
findings were observed in Myb+/ chimeras (unpublished data). 
In a third possible scenario, a lack of transcription factors nec-
essary for Ly49A expression could explain the reduction of 
Ly49A subset in miR-150Tg and Myb+/ NK cells. Gata-3 has 
been shown to be a direct target of c-Myb (Maurice et al., 
2007), and Gata-3 deficiency leads to a reduction of the Ly49A 
subset of NK cells (Samson et al., 2003). Trans-acting factor 
transcription factor-1 has been shown to bind the Klra1 pro-
moter and regulate the Ly49A-bearing NK cell subset in a 
dosage-dependent manner (Held et al., 1999). Putative bind-
ing sites for the transcription factors Runx1 and Atf2 have also 
been suggested to control Ly49A expression (Kubo et al., 
1999; Kunz and Held, 2001), but at least in the case of Atf2, 
the Ly49 receptor repertoire analysis does not seem to indicate 
a requirement for this transcription factor for Ly49A expres-
sion (Kim et al., 2006). Lastly, it is possible that c-Myb itself 
binds to and regulates the Klra1. A c-Myb–binding sequence is 
found in the upstream region of Klra1 (Tanamachi et al., 2004), 
and we find that the size of the Ly49A-expressing NK cell 
subset is dependent on the dosage of c-Myb. Future studies 
in c-Myb–deficient NK cells will definitively prove whether 
c-Myb is necessary for the acquisition of Ly49A.
We find that miR-150 differentially affects the develop-
ment of NK and iNKT cell lineages. The literature supports 
the notion that miR-150 plays different roles depending on 
cell context. Forced expression of miR-150 promoted prolif-
eration of gastric cancer cells (Wu et al., 2010), whereas it 
increased the rate of apoptosis and reduced proliferation of 
NK/T lymphoma cells (Watanabe et al., 2011). miR-150Tg 
mice have a reduced number of splenic B cells, and miR-150Tg 
B cells from the BM showed increased sensitivity to apoptosis 
when cultured in vitro (Xiao et al., 2007). In contrast, there 
was an accumulation of NK cells in miR-150Tg chimeric 
mice and no difference was seen in the rate of apoptosis 
between WT and miR-150Tg NK cells. The differences in 
susceptibility to apoptosis can be partially explained by the 
higher frequency of mature NK cells and greater percentage 
of immature B cells (Xiao et al., 2007), but the maturation 
status alone is probably insufficient to explain the entire 
phenotype of miR-150Tg NK cells. B cells depend on positive 
signaling through the B cell receptor to promote survival and 
terminal differentiation (Meffre et al., 2001). B-1 B cells, 
which require strong BCR signaling to develop (Hayakawa 
et al., 1999), are significantly reduced in miR-150Tg mice 
(Xiao et al., 2007). The opposite is true for NK cells, which 
rely on negative signaling through the inhibitory receptors 
to reach a mature, functionally competent state (Fernandez 
et al., 2005; Kim et al., 2005; Anfossi et al., 2006). Future 
studies will examine how miR-150 effects the survival of 
iNKT cells. Whereas c-Myb is necessary for the survival of 
double-positive thymocytes (Bender et al., 2004), ectopic 
expression of miR-150 did not significantly effect T cell 
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Ex vivo stimulation assay. Splenocytes were stimulated in Immulon 
microtiter plates (Thermo Fisher Scientific) coated with 10 µg anti-NK1.1, 
anti-Ly49H, or control IgG in PBS for 4 h at 37°C in the presence of Golgi-
Stop (BD), followed by staining for intracellular IFN- (BD). For cytokine 
stimulation, splenocytes were incubated with 20 ng/ml IL-12 (R&D Sys-
tems) and 10 ng/ml IL-18 (R&D Systems).
Cell sorting. NK cells from spleen were enriched with antibodies against 
CD5, CD4, CD8, Ter119, Gr-1, CD19 (UCSF Antibody Core), and 
anti–rat IgG-coated magnetic beads (Miltenyi Biotec). NK cells were stained 
with antibodies against NK1.1, TCR, CD45.1, CD45.2, NK1.1, TCR, 
CD11b, and CD27 and were sorted using a FACSAria (BD). NK popula-
tions from the BM were sorted using antibodies against CD4, CD8, CD19, 
GR-1, CD11c, Ter119, CD122, NK1.1, CD51, and CD49b. Thymic 
iNKT cells were sorted with PBS57-loaded CD1d tetramer and antibodies 
against NK1.1, TCR, and CD24. The purity of the recovered populations 
was typically >98%.
Quantitative RT-PCR (qRT-PCR). Total RNA was extracted from 
sorted cells with RNAqueous-Micro kit (Invitrogen). miR-150 expres-
sion was examined by using the TaqMan MicroRNA Assay kit (Applied 
Biosystems) with gene-specific stem-loop PCR primers and TaqMan probe 
(IDT). SnoRNA202 was used as endogenous control. cDNA was gener-
ated by using a SuperScript III First-Strand kit (Invitrogen) and real-time 
PCR was performed on an Applied Biosystems 7500. PCR of cDNA was 
conducted using ABI TaqMan kits (c-Myb and HPRT) or SYBR Green 
PCR Master Mix (Invitrogen). The primer sequences for SYBR green 
PCR reactions were as follows: c-kit, forward, 5-TCATCGAGTGTGAT-
GGGAAA-3; reverse, 5-GGTGACTTGTTTCAGGCACA-3; Bcl2, 
forward, 5-TACCGTCGTGACTTCGCAGAG-3; reverse, 5-GGCAG-
GCTGAGCAGGGTCTT-3; HPRT, forward, 5-CACAGGACTAGAA-
CACCTGC-3; reverse, 5-GCTGGTGAAAAGGACCTCT-3. Data were 
analyzed by the CT method (Livak and Schmittgen, 2001).
Statistical analysis. All data shown are the mean ± SEM. Comparisons be-
tween samples were performed by using a two-tailed unpaired Student’s 
t test, unless otherwise stated. Statistics were calculated using Prism software 
(GraphPad Software, Inc.). P values were denoted in the following manner: 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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